IBDEI064 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7958,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7958,1,1,0)
 ;;=1^284.2
 ;;^UTILITY(U,$J,358.3,7958,1,8,0)
 ;;=8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,7958,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,7959,0)
 ;;=281.9^^45^462^8
 ;;^UTILITY(U,$J,358.3,7959,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7959,1,1,0)
 ;;=1^281.9
 ;;^UTILITY(U,$J,358.3,7959,1,8,0)
 ;;=8^Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,7959,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,7960,0)
 ;;=284.89^^45^462^5
 ;;^UTILITY(U,$J,358.3,7960,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7960,1,1,0)
 ;;=1^284.89
 ;;^UTILITY(U,$J,358.3,7960,1,8,0)
 ;;=8^Anemia d/t CA or Drugs
 ;;^UTILITY(U,$J,358.3,7960,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,7961,0)
 ;;=281.1^^45^462^7
 ;;^UTILITY(U,$J,358.3,7961,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7961,1,1,0)
 ;;=1^281.1
 ;;^UTILITY(U,$J,358.3,7961,1,8,0)
 ;;=8^B12 Defic Anemia NEC
 ;;^UTILITY(U,$J,358.3,7961,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,7962,0)
 ;;=281.2^^45^462^9
 ;;^UTILITY(U,$J,358.3,7962,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7962,1,1,0)
 ;;=1^281.2
 ;;^UTILITY(U,$J,358.3,7962,1,8,0)
 ;;=8^Folate-Def Anemia
 ;;^UTILITY(U,$J,358.3,7962,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,7963,0)
 ;;=282.60^^45^462^18
 ;;^UTILITY(U,$J,358.3,7963,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7963,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,7963,1,8,0)
 ;;=8^Sickle Cell Anemia NOS
 ;;^UTILITY(U,$J,358.3,7963,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,7964,0)
 ;;=285.0^^45^462^19
 ;;^UTILITY(U,$J,358.3,7964,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7964,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,7964,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,7964,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,7965,0)
 ;;=286.9^^45^463^2
 ;;^UTILITY(U,$J,358.3,7965,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7965,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,7965,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,7965,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,7966,0)
 ;;=446.6^^45^463^9
 ;;^UTILITY(U,$J,358.3,7966,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7966,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,7966,1,8,0)
 ;;=8^Thrombotic Thrombocytopenic Purpura (TTP)
 ;;^UTILITY(U,$J,358.3,7966,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,7967,0)
 ;;=451.9^^45^463^8
 ;;^UTILITY(U,$J,358.3,7967,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7967,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,7967,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,7967,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,7968,0)
 ;;=287.5^^45^463^6
 ;;^UTILITY(U,$J,358.3,7968,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7968,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,7968,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,7968,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,7969,0)
 ;;=287.1^^45^463^5
 ;;^UTILITY(U,$J,358.3,7969,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7969,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,7969,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,7969,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,7970,0)
 ;;=287.30^^45^463^4
 ;;^UTILITY(U,$J,358.3,7970,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7970,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,7970,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,7970,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,7971,0)
 ;;=238.71^^45^463^7
 ;;^UTILITY(U,$J,358.3,7971,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7971,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,7971,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,7971,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,7972,0)
 ;;=286.0^^45^463^1
 ;;^UTILITY(U,$J,358.3,7972,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7972,1,1,0)
 ;;=1^286.0
 ;;^UTILITY(U,$J,358.3,7972,1,8,0)
 ;;=8^Congenital Factor VIII
 ;;^UTILITY(U,$J,358.3,7972,2)
 ;;=^27454
 ;;^UTILITY(U,$J,358.3,7973,0)
 ;;=275.03^^45^463^3
 ;;^UTILITY(U,$J,358.3,7973,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7973,1,1,0)
 ;;=1^275.03
 ;;^UTILITY(U,$J,358.3,7973,1,8,0)
 ;;=8^Hemochromatosis NEC
 ;;^UTILITY(U,$J,358.3,7973,2)
 ;;=^339604
 ;;^UTILITY(U,$J,358.3,7974,0)
 ;;=205.00^^45^464^1
 ;;^UTILITY(U,$J,358.3,7974,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7974,1,1,0)
 ;;=1^205.00
 ;;^UTILITY(U,$J,358.3,7974,1,8,0)
 ;;=8^A M L, W/O Remission
 ;;^UTILITY(U,$J,358.3,7974,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,7975,0)
 ;;=205.01^^45^464^2
 ;;^UTILITY(U,$J,358.3,7975,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7975,1,1,0)
 ;;=1^205.01
 ;;^UTILITY(U,$J,358.3,7975,1,8,0)
 ;;=8^A M L,In Remission
 ;;^UTILITY(U,$J,358.3,7975,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,7976,0)
 ;;=205.10^^45^464^4
 ;;^UTILITY(U,$J,358.3,7976,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7976,1,1,0)
 ;;=1^205.10
 ;;^UTILITY(U,$J,358.3,7976,1,8,0)
 ;;=8^C M L,W/O Remission
 ;;^UTILITY(U,$J,358.3,7976,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,7977,0)
 ;;=205.11^^45^464^3
 ;;^UTILITY(U,$J,358.3,7977,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7977,1,1,0)
 ;;=1^205.11
 ;;^UTILITY(U,$J,358.3,7977,1,8,0)
 ;;=8^C M L,In Remission
 ;;^UTILITY(U,$J,358.3,7977,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,7978,0)
 ;;=289.0^^45^464^7
 ;;^UTILITY(U,$J,358.3,7978,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7978,1,1,0)
 ;;=1^289.0
 ;;^UTILITY(U,$J,358.3,7978,1,8,0)
 ;;=8^Secondary Polycythemia
 ;;^UTILITY(U,$J,358.3,7978,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,7979,0)
 ;;=238.4^^45^464^6
 ;;^UTILITY(U,$J,358.3,7979,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7979,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,7979,1,8,0)
 ;;=8^Polycythemia Rubra Vera
 ;;^UTILITY(U,$J,358.3,7979,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,7980,0)
 ;;=288.9^^45^464^9
 ;;^UTILITY(U,$J,358.3,7980,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7980,1,1,0)
 ;;=1^288.9
 ;;^UTILITY(U,$J,358.3,7980,1,8,0)
 ;;=8^Unspecified Dis Of W B C
 ;;^UTILITY(U,$J,358.3,7980,2)
 ;;=^267993
 ;;^UTILITY(U,$J,358.3,7981,0)
 ;;=289.81^^45^464^8
 ;;^UTILITY(U,$J,358.3,7981,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7981,1,1,0)
 ;;=1^289.81
 ;;^UTILITY(U,$J,358.3,7981,1,8,0)
 ;;=8^Unspecified Blood Diseases
 ;;^UTILITY(U,$J,358.3,7981,2)
 ;;=^329886
 ;;^UTILITY(U,$J,358.3,7982,0)
 ;;=238.75^^45^464^5
 ;;^UTILITY(U,$J,358.3,7982,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7982,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,7982,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,7982,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,7983,0)
 ;;=204.00^^45^465^2
 ;;^UTILITY(U,$J,358.3,7983,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7983,1,1,0)
 ;;=1^204.00
 ;;^UTILITY(U,$J,358.3,7983,1,8,0)
 ;;=8^A L L,W/O Remission
 ;;^UTILITY(U,$J,358.3,7983,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,7984,0)
 ;;=204.01^^45^465^1
 ;;^UTILITY(U,$J,358.3,7984,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7984,1,1,0)
 ;;=1^204.01
 ;;^UTILITY(U,$J,358.3,7984,1,8,0)
 ;;=8^A L L, In Remission
 ;;^UTILITY(U,$J,358.3,7984,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,7985,0)
 ;;=204.10^^45^465^5
 ;;^UTILITY(U,$J,358.3,7985,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7985,1,1,0)
 ;;=1^204.10
 ;;^UTILITY(U,$J,358.3,7985,1,8,0)
 ;;=8^C L L,W/O Remission
 ;;^UTILITY(U,$J,358.3,7985,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,7986,0)
 ;;=204.11^^45^465^4
 ;;^UTILITY(U,$J,358.3,7986,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7986,1,1,0)
 ;;=1^204.11
 ;;^UTILITY(U,$J,358.3,7986,1,8,0)
 ;;=8^C L L,In Remission
 ;;^UTILITY(U,$J,358.3,7986,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,7987,0)
 ;;=201.90^^45^465^8
 ;;^UTILITY(U,$J,358.3,7987,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7987,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,7987,1,8,0)
 ;;=8^Hodgkins Lymphoma,Unspec Type
 ;;^UTILITY(U,$J,358.3,7987,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,7988,0)
 ;;=202.00^^45^465^14
 ;;^UTILITY(U,$J,358.3,7988,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7988,1,1,0)
 ;;=1^202.00
 ;;^UTILITY(U,$J,358.3,7988,1,8,0)
 ;;=8^Lymphoma, Low-Grade (Nodular)
 ;;^UTILITY(U,$J,358.3,7988,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,7989,0)
 ;;=200.20^^45^465^15
 ;;^UTILITY(U,$J,358.3,7989,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7989,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,7989,1,8,0)
 ;;=8^Lymphoma,Burkitts
 ;;^UTILITY(U,$J,358.3,7989,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,7990,0)
 ;;=202.10^^45^465^23
 ;;^UTILITY(U,$J,358.3,7990,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7990,1,1,0)
 ;;=1^202.10
 ;;^UTILITY(U,$J,358.3,7990,1,8,0)
 ;;=8^Mycosis Fungoides
 ;;^UTILITY(U,$J,358.3,7990,2)
 ;;=^80360
 ;;^UTILITY(U,$J,358.3,7991,0)
 ;;=273.3^^45^465^19
 ;;^UTILITY(U,$J,358.3,7991,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7991,1,1,0)
 ;;=1^273.3
 ;;^UTILITY(U,$J,358.3,7991,1,8,0)
 ;;=8^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,7991,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,7992,0)
 ;;=203.00^^45^465^22
 ;;^UTILITY(U,$J,358.3,7992,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7992,1,1,0)
 ;;=1^203.00
 ;;^UTILITY(U,$J,358.3,7992,1,8,0)
 ;;=8^Multiple Myeloma,W/O Remission
 ;;^UTILITY(U,$J,358.3,7992,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,7993,0)
 ;;=203.01^^45^465^21
 ;;^UTILITY(U,$J,358.3,7993,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7993,1,1,0)
 ;;=1^203.01
 ;;^UTILITY(U,$J,358.3,7993,1,8,0)
 ;;=8^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,7993,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,7994,0)
 ;;=202.40^^45^465^7
 ;;^UTILITY(U,$J,358.3,7994,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7994,1,1,0)
 ;;=1^202.40
 ;;^UTILITY(U,$J,358.3,7994,1,8,0)
 ;;=8^Hairy-Cell Leukemia
 ;;^UTILITY(U,$J,358.3,7994,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,7995,0)
 ;;=200.10^^45^465^17
 ;;^UTILITY(U,$J,358.3,7995,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,7995,1,1,0)
 ;;=1^200.10
 ;;^UTILITY(U,$J,358.3,7995,1,8,0)
 ;;=8^Lymphoma,Int/High (Diffuse)
 ;;^UTILITY(U,$J,358.3,7995,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,7996,0)
 ;;=273.1^^45^465^20
 ;;^UTILITY(U,$J,358.3,7996,1,0)
 ;;=^358.31IA^8^2
